Peptide / Metabolic

SHU9119

MC3R/MC4R antagonist — blocks the anorexigenic pathway. Experimental compound for appetite stimulation research. Opposite mechanism to PT-141.

Build protocol outline Open dose calculator TNHL ebooks

Educational reference only. This page does not diagnose, prescribe, or replace care from a licensed professional. Laws, availability, and clinical appropriateness vary by location.

Reference doseResearch only — no established human dose

Half-life0.5 hours

Risk flaghigh

Regulatory noteResearch-only flag

Side effects and watch-outs

⚠️ No established human safety data
Significant appetite stimulation
Possible cardiovascular effects
Theoretical: metabolic disruption
NOT recommended for unsupervised use